Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says

Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says

https://youtube.com/watch?v=xQ_G4xrysT8

Aug.28 — John Thero, Amarin Corp. chief executive officer, discusses the company’s plans for its cardiovascular drug Vascepa. He speaks with Bloomberg’s David Westin on “Balance of Power.”

SHARE IT:

Leave a Reply